Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

CompletedOBSERVATIONAL
Enrollment

265

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Chronic Kidney DiseaseSecondary Hyperparathyroidism
Trial Locations (11)

11528

Site Reference ID/Investigator# 53424, Athens

26225

Site Reference ID/Investigator# 66291, Pátrai

26504

Site Reference ID/Investigator# 56809, Pátrai

31100

Site Reference ID/Investigator# 56805, Lefkada

38221

Site Reference ID/Investigator# 53422, Volos

41223

Site Reference ID/Investigator# 53425, Larissa

47100

Site Reference ID/Investigator# 56803, Arta

57001

Site Reference ID/Investigator# 50442, Pylaia Thessaloniki

151 27

Site Reference ID/Investigator# 56802, Melíssia

570 01,

Site Reference ID/Investigator# 77554, Thessaloniki

570 19

Site Reference ID/Investigator# 77553, Thessaloniki

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01368042 - Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous | Biotech Hunter | Biotech Hunter